fda warning letter hims compounded semaglutide september 2025 15, 2025: Telehealth company must stop implying its GLP-1 is FDA-approved, warns – Partnership for Safe Medicines Hims & Hers stock crashes

Every order includes clear handling instructions and storage guidelines (20C or colder)

In the cardiovascular system, GLP-1R engagement exerts cardioprotective effects and attenuates systemic inflammation

Consent for publication The authors confirm that the work has not been published before or elsewhere

M., Alini, M., & Grad, S

These include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (very common) Vomiting (common, affecting up to 1 in 10 people) Constipation (common) Abdominal pain (common) Reduced appetite (very common) These gastrointestinal effects typically occur during dose escalation and often diminish over time as the body adjusts to the medication

The administration of semaglutide in rodent stroke models decreased NLRP3 expression in microglial cells, which resulted in better neurological recovery [13]